Barrett's Esophagus Clinical Trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 349 clinical trials
HOPE in Action Prospective Multicenter Clinical Trial of HIV+ Deceased Donor Kidney Transplants for HIV+ Recipients

Use of an HIV+ deceased donor could increase the risk of death, transplant-related or HIV-related complications; alternatively with effective antiretroviral treatment and careful HIV+ donor selection, these risks may be comparable to kidney transplant using an HIV-negative donor. We hypothesize that receiving a kidney transplant from an HIV+ donor will …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Cardiovascular Inflammation Reduction Trial (CIRT): A randomized double-blind placebo controlled event-driven trial of weekly low-dose methotrexate (LDM) in the prevention of recurrent cardiovascular events among stable post-myocardial infarction patients with type 2 diabetes or metabolic syndrome

Only those who qualify will be enrolled, randomized and given either 15-20 mg of the drug or placebo each week for dash months. For the first six months visits will be scheduled at least once every month following which bi-monthly evaluations will be done.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Giant Cell Arteritis

Patients with new onset GCA or those with disease relapse may be eligible to take part. Participants will be assigned at random to receive either sarilumab plus prednisone or a placebo plus prednisone.

  • 0 views
  • 19 Feb, 2024
  • 1 location
An Open-Label Phase 1 Study to Evaluate the Safety of ATA188 in Subjects with Progressive and Relapsing-Remitting Multiple Sclerosis

Up to 42 male or female subjects with progressive forms of MS and 42 subjects with Relapsing-Remitting MS will be enrolled. The subjects will be randomized to receive study drug or placebo and will receive 2 treatment cycles followed by 11 monthly follow-up visits.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients

The THINKER-NEXT research study is being done to determine whether it is safe to give a kidney transplant from a donor with hepatitis C to a patient without hepatitis C. The recipient will then be given a drug called Epclusa for 12 weeks to treat hepatitis C. Patients who are …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Substrate targeted ablation using the Cool Flex catheter ablation system for the reduction of Ventricular Tachycardia

So, if patient has MMVT and ICD implanted they will either be randomized to VT ablation with the Coolflex catheter system OR randomized to study drug (standard AAD medication) If they do not have MMVT then they will be placed in a registry.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A randomized double-blind placebo controlled multi-center study to assess the effect of ranolazine on outcomes in subjects with pulmonary hypertension and right ventricular dysfunction accompanied by a comparative study of cellular metabolism in subjects with pulmonary hypertension with and without right ventricular dysfunction

At baseline (wk 0), interim (wk 13) and the conclusion of treatment period (wk 26) subjects will be assessed for functional class, 6- MWD, and QOL based on SF-36 tool. Subjects will be assessed with echo and peripheral blood will be obtained for metabolic profiling at baseline and the conclusion …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Radiation Oncology Registry

Participation in this study requires no additional obligations on your part; your participation means you are granting permission for your doctors to extract information from your medical chart and use this data for research purposes. Should any findings from this research be presented or published, your name, date of birth, …

  • 0 views
  • 19 Feb, 2024
  • 1 location
ConsCIOUS2: A Prospective Study of the Isolated Forearm Technique Commands Long-term Sequelae and Electroencephalograph Correlates Following Laryngoscopy and Intubation in patients 18 - 40 years of age

This a multi-center prospective cohort study of a series of commands surveying responsiveness following laryngoscopy and intubation. Clinical care will not be controlled and will be left to local policy. We will also collect routinely recorded clinical data to frame the observations about IFT responsiveness (please see list below and …

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Phase 2/3 Randomized Open-Label Study of Toca 511 a Retroviral Replicating Vector Combined With Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma

Crossover to the Experimental arm is not allowed, unless the primary endpoint is met and the Sponsor notifies the sites. An Independent Data Monitoring Committee (IDMC) will be convened to review safety data on a periodic basis. An efficacy analysis is planned to be conducted when 108 events (deaths) have …

  • 0 views
  • 19 Feb, 2024
  • 1 location